Foreign fund Morgan Stanley has consolidated its stake in
Aurobindo Pharma by acquiring an additional 4.16 per cent stake
through open market route.
Morgan Stanley acquired 22.37 lakh equity shares amounting to 4.16 per
cent stake in Aurobindo Pharma on August 1 by way of open market
transaction, the pharma company said in a disclosure to the Bombay
Stock Exchange.
Calculating on the basis of the closing price of Aurobindo Pharma on
August 1, Morgan Stanley acquired the stake for over Rs 137 crore.
After the acquisition, Morgan Stanley now holds 6.15 per cent stake in
Aurobindo Pharma with 33.07 lakh equity shares.
Before the acquisition, the foreign fund had held 10.70 lakh shares,
accounting for 1.99 per cent stake in the domestic pharma company.
Shares of Aurobindo Pharma closed at Rs 632, up 0.61 per cent on BSE
Aurobindo Pharma by acquiring an additional 4.16 per cent stake
through open market route.
Morgan Stanley acquired 22.37 lakh equity shares amounting to 4.16 per
cent stake in Aurobindo Pharma on August 1 by way of open market
transaction, the pharma company said in a disclosure to the Bombay
Stock Exchange.
Calculating on the basis of the closing price of Aurobindo Pharma on
August 1, Morgan Stanley acquired the stake for over Rs 137 crore.
After the acquisition, Morgan Stanley now holds 6.15 per cent stake in
Aurobindo Pharma with 33.07 lakh equity shares.
Before the acquisition, the foreign fund had held 10.70 lakh shares,
accounting for 1.99 per cent stake in the domestic pharma company.
Shares of Aurobindo Pharma closed at Rs 632, up 0.61 per cent on BSE
No comments:
Post a Comment